Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | GLRA1 | P23415 | 3/20 | 0.32 |
| ▸ | GLRA2 | P23416 | 3/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GUSB | P08236 | 1/20 | 0.32 |
| ▸ | PTAFR | P25105 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bilobalide SCHEMBL19236272 | 1.00 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| Bilobalide SCHEMBL29410808 | 1.00 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| Bilobalide SCHEMBL14029382 | 1.00 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| Bilobalide SCHEMBL29410789 | 1.00 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| Bilobalide SCHEMBL16653675 | 1.00 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| Bilobalide SCHEMBL18327718 | 1.00 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| Bilobalide SCHEMBL13960090 | 1.00 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| Bilobalide SCHEMBL16452769 | 1.00 | KMT2A (1.00) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| SCHEMBL29974351 | 0.84 | MEN1 (0.72) | KMT2AMEN1SMN1; SMN2THRBALOX15 | |
| SCHEMBL31364706 | 0.79 | MEN1 (0.65) | KMT2AMEN1SMN1; SMN2THRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5266 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005544-A | Method for preparing VA-ECMO lung injury treatment drug by using ginkgolide A to regulate YARS1 | 中国人民解放军总医院第八医学中心 | 2026-05-12 | — | — | CN | claimed |
| US-12622941-B2 | Anticoccidial composition comprising ginkgo leaves and use thereof | CJ CHEILJEDANG CORPORATION (KR) | 2026-05-12 | — | — | US | claimed |
| CN-122029157-A | Bilobalide derivatives for the treatment of neurological diseases and cancers | 香港中文大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122012537-A | Gene GbCYP A6 for promoting synthesis of ginkgolide and application thereof | 扬州大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4405047-B1 | CANNABINOID FORMULATION FOR ORAL ADMINISTRATION | CB21 PHARMA S R O (CZ) | 2026-04-01 | — | — | EP | claimed |
| EP-3782619-B1 | USE OF GINKGO BILOBA TERPENE LACTONE IN PREPARATION OF DRUGS FOR PREVENTION AND/OR TREATMENT OF TREMORS AND HEALTHCARE PRODUCTS | CHENGDU BAIYU PHARMACEUTICAL CO LTD (CN) | 2026-02-25 | — | — | EP | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| US-12545694-B2 | Cannabidiol derivatives, preparation method thereof and use thereof | CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) | 2026-02-10 | — | — | US | claimed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | claimed |
| US-12390503-B2 | Ginkgo biloba leave extract capsule and preparation method therefor | SPH XING LING SCI. & TECH. PHARMACEUTICAL CO., LTD. (CN) | 2025-08-19 | — | — | US | claimed |
| US-5264216-A | Treatment of bacterial infections | INDENA SPA (IT) | 1993-11-23 | — | — | US | claimed |
| EP-0556051-A1 | Use of bilobalide and derivatives thereof for treating an infection in an individual and pharmaceutical compositions adapted for such use | INDENA S.p.A. (IT) | 1993-08-18 | — | — | EP | claimed |
| EP-0360556-B1 | NEW EXTRACTS OF GINKGO BILOBA AND THEIR METHODS OF PREPARATION | INDENA S.p.A. (IT) | 1993-04-21 | — | — | EP | claimed |
| US-5202313-A | Complexes with phospholipids; antiinflammatory agents | INDENA S.P.A. (IT) | 1993-04-13 | — | — | US | claimed |
| EP-0477968-A1 | Extract from Ginkgo biloba leaves, in particular for intravenous injection or infusion, a method of preparation of the extract and ampoule preparations containing the extract | Dr. Willmar Schwabe GmbH & Co. (DE) | 1992-04-01 | — | — | EP | claimed |
| EP-0441279-A1 | Bilobalide phospholipide complexes, their applications and formulations containing them | INDENA S.p.A. (IT) | 1991-08-14 | — | — | EP | claimed |
| EP-0436129-A1 | Active component concentrates and new active component combinations from Ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations | WALLINGSTOWN COMPANY LIMITED (IE) | 1991-07-10 | — | — | EP | claimed |
| EP-0431535-A1 | Extract from Ginkgo biloba leaves, its method of preparation and pharmaceuticals containing the extract | Dr. Willmar Schwabe GmbH & Co. (DE) | 1991-06-12 | — | — | EP | claimed |
| EP-0431536-A1 | A method of preparation of an extract from Gingko biloba leaves. | Dr. Willmar Schwabe GmbH & Co. (DE) | 1991-06-12 | — | — | EP | claimed |
| US-4892883-A | Pharmaceutical compositions containing bilobalide for the treatment of neuropathies Ai | WILLMAN - SCHWABE GMBH & CO. (DE) | 1990-01-09 | — | — | US | claimed |